Cidara Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 12, 2016 17:12 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 12, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update
March 18, 2016 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 18, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Positive Data From Phase 1 Clinical Trial of CD101 IV and Reports Third Quarter 2015 Financial Results
November 16, 2015 16:13 ET
|
Cidara Therapeutics, Inc.
-- Single Ascending Dose Study-Results Demonstrate Excellent Safety and Tolerability and Support Once-Weekly IV Dosing --
-- Management to Host Webcast and Conference Call Tomorrow at 8:00 a.m. ET...
Cidara Therapeutics to Present at the Jefferies 2015 Global Healthcare Conference in London
November 10, 2015 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
Cidara Reports Second Quarter 2015 Financial Results and Provides Corporate Update
August 11, 2015 16:13 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 11, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
Cidara Therapeutics to Present at the Wedbush PacGrow 2015 Healthcare Conference
August 05, 2015 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
Cidara Reports First Quarter 2015 Financial Results and Provides Corporate Update
May 21, 2015 16:25 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, May 21, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other infections,...
Cidara Therapeutics Announces Pricing of Initial Public Offering
April 15, 2015 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, April 15, 2015 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...